Association of TAP1 and TAP2 with systemic sclerosis in Japanese

Clinical and Experimental Rheumatology

Volumn 14, Issue 5, 1996, Pages 513-521

  Takeuchi, F ^a   Kuwata, S ^a   Nakano, K ^a   Nabeta, H ^a   Hong, G H ^a   Shibata, Y ^a   Tanimoto, K ^b   Ito, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b SAITAMA UNIVERSITY   (Japan)

Author keywords

anti Scl 70 antibody; Japanese; polymorphism; systemic sclerosis; TAP

Indexed keywords

TAP 1; TAP 2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GEOGRAPHIC PATHOLOGY; HLA TYPING; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN TRANSPORT; SYSTEMIC SCLEROSIS;

ADULT; ALLELES; ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; AUTOANTIBODIES; FEMALE; GENOTYPE; HLA-DR ANTIGENS; HUMANS; JAPAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SCLERODERMA, SYSTEMIC;

EID: 0029841856     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. MASI AT, RODMAN GP, MEDSGER TA JR, ALTMAN RD, D'ANGELO WA, FRIES JF, LEROY EC, KIRSNER AB, MACKENZIE AH, MCSHANE DJ, MYERS AR, SHARP GC: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
2. LEROY EC, BLACK C, FLEISCHMAJER R, JABLONSKA S, KRIEG T, MEDSGER TA JR, ROWELL N, WOLLHEIM F: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
3. BRIGGS D, BLACK C, WELSH K: Genetic factors in scleroderma. Rheum Dis Clin North Am 1990; 16: 31-51.
4. SASAKI T, DENPO K, ONO H, NAKAJIMA H: HLA in systemic scleroderma (PSS) and familial scleroderma. J Dermatol 1991; 18: 18-24.
5. TAKEUCHI E, NAKANO K, YAMADA H, HONG GH, NABETA H, YOSHIDA A, MATSUTA K, BANNAI M, TOKUNAGA K, ITO K: Association of HLA-DR with progressive systemic sclerosis in Japanese. J Rheumatol 1994; 21: 857-63.
6. KUWANA M, KABURAKI J, OKAMOTO Y, INOKO H, TSIIJI K: The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma). J Clin Invest 1993; 92: 1296-301.
7. STEEN VD, POWELL DL, MEDSGER TA JR: Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988; 31: 196-203.
8. BRIGGS DC, WELSH K, PEREIRA RS, BLACK CM: A strong association between null alleles at the C4A locus in the major histocompatibility complex and systemic sclerosis. Arthritis Rheum 1986; 29: 1274-7.
9. BLACK CM, WELSH KI, MADDISON PJ, JAYSON MI, BERNSTEIN RM: HLA-antigens, autoantibodies and clinical subsets in scleroderma. Br J Rheumatol 1984; 23: 267-71.
10. BARNETT AJ, TAIT BD, BARNETT MA, TOH BH: T lymphocyte subset abnormalities and HLA antigens in scleroderma (systemic sclerosis). Clin Exp Immunol 1989; 76: 24-9.
11. GENTH E, MIERAU R, GENETZKY P, VON MUHLEN CA, KAUFMANN S, VON WILMOWSKY H, MEURER M, KRIEG T, POLLMANN HJ, HARTL PW: Immunogenetic associations of scleroderma-related antinuclear antibodies. Arthritis Rheum 1990; 33: 657-65.
12. DUNCKLEY H, JAZWINSKA EC, GATENBY PA, SERJEANTSON SW: DNA-DR typing shows HLA-DRwI 1 RFLPs are increased in frequency in both progressive systemic sclerosis and CREST variants of scleroderma. Tissue Antigens 1989; 33: 418-20.
13. REVEILLE JD, OWERBACH D, GOLDSTEIN R, MOREDA R, ISERN RA, ARNETT FC: Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma). J Clin Invest 1992; 89: 1208-13.
14. REVEILLE JD, DURBAN E, MACLEOD-ST. CLAIR MJ, GOLDSTEIN R, MOREDA R, ALTMAN RD, ARNETT FC: Association of amino acids sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest 1992; 90: 973-80.
15. MOLLENHAUER E, SCHMIDT R, HEINRICHS M, RITTNER C: Scleroderma: possible significance of silent alleles at the C4B locus. Arthritis Rheum 1984; 27: 711-2.
16. NAKANO K, YAMADA H, TAKEUCHI F, MATSUTA K, TOKUNAGA K, MOROI Y: Genetic factor in systemic sclerosis. 1991 Annual Report of the Ministry of Health and Welfare Scleroderma Research Committee 1992: 50-3 (in Japanese).
17. DEVERSON EV, GOW IR, COADWELL WJ, MONACO JJ, BUTCHER GW, HOWARD JC: MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporter. Nature 1990; 348: 738-41 .
18. TROWSDALE J, HANSON I, MOCKRIDGE I, BECK S, TOWNSEND A, KELLY A: Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters. Nature 1990; 348: 741-4.
19. SPIES T, BRESNAHAN M, BAHRAM S, ARNOLD D, BLANCK G, MELLINS E, PIOUS D, DEMARS R: A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature 1990; 348: 744-7.
20. MONACO JJ, CHO S, ATTAYA M: Transport protein genes in the murine MHC: Possible implications for antigen processing. Science 1990; 250: 1723-6.
21. KELLY A, POWIS SH, KERR LA, MOCKRIDGE I, ELLIOTT T, BASTIN J, UCHANSKA-ZIEGLER B, ZIEGLER A, TROWSDALE J, TOWNSEND A: Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature 1992; 355: 641-644.
22. SPIES T, CERUNDOLO V, COLONNA M, CRESSWELL P, TOWNSEND A, DEMARS R: Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature 1992; 355: 644-6.
23. CARRINGTON M, COLONNA M, SPIES T, STEPHENS JC, MANN DL: Haplotypic variation of the transporter association with antigen processing (TAP) genes and their extension of HLA class II region haplotypes. Immunogenetics 1993; 37: 266-73.
24. POWIS SH, TONKS S, MOCKRIDGE I, KELLY AP, BODMER JG, TROWSDALE J: Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2. Immunogenetics 1993; 37: 373-80.
25. POWIS SH, ROSENBERG WMC, HALL M, MOCKRIDGE I, TONKS S, IVINSON A, CICLITIRA PJ, JEWELL DP, LANCHBURY JS, BELL JI, TROWSDALE J: TAP1 and TAP2 polymorphism in coeliac disease. Immunogenetics 1993; 38: 345-50.
26. HILL A, PLOEGH H: Getting the inside out: The transporter association with antigen processing (TAP) and the presentation of viral antigen. Proc Natl Acad Sci USA 1995; 92: 341-3.
27. POWIS SJ, DEVERSON EV, COADWELL WJ, CIRUELA A, HUSKISSON NS, SMITH H, BUTCHER GW, HOWARD JC: Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule. Nature 1992; 357: 211-5.
28. MOMBURG F, ROELSE J, HAMMERLING GJ, NEEFES JJ: Peptide size selection by the major histocompatibility complex-encoded peptide transporter. J Exp Med 1994; 179: 1613-23.
29. MALNATI MS, MARTI M, LAVAUTE T, JARAQUEMADA D, BIDDISON W, DEMARS R, LONG EO: Processing pathways for presentation of cytosolic antigen to MIIC class II-restricted T cells. Nature 1992; 357: 702-4.
30. KUWATA S, YANAGISAWA M, SAEKI H, NAKAGAWA H, ETOH T, TOKUNAGA K, JUJI T, SHIBATA Y: Lack of primary association between transporter associated with antigen processing genes and atopic dermatitis. J Allergy Clin Immunol 1995; 96: 1051-60.
31. TIGHE MR, HALL MA, CARDI E, ASHKENAZI A, LANCHBURY JS, CICLITIRA PJ: Associations between alleles of the major histocompatibility complex-encoded ABC transporter gene TAP2, HLA class II alleles, and celiac disease susceptibility. Hum Immunol 1994; 39: 9-16.
32. KELLAR-WOOD HF, POWIS SH, GRAY J, COMPSTON DA: MHC-encoded TAP1 and TAP2 dimorphisms in multiple sclerosis. Tissue Antigens 1994; 43: 129-32.
33. SPURKLAND A, KNUTSEN I, UNDLIEN DE, VARTDAL F: No association of multiple sclerosis to alleles at the TAP2 locus. Hum Immunol 1994; 39: 299-301.
34. VAN ENDERT PM, LIBLAU RS, PATEL SD, FUGGER L, LOPEZ T, POCIOT F, NERUP J, MCDEVITT HO: Major histocompatibility complex-encoded antigen processing gene polymorphism in IDDM. Diabetes 1994; 43: 110-7.
35. RONNINGEN KS, UNDLIEN DE, PLOSKI R, MAOUNI N, KONRAD RJ, JENSEN E, HORNES E, REIJONEN H, COLONNA M, MONOS DS: Linkage disequilibrium between TAP2 variants and HLA class II alleles: no primary association between TAP2 variants and insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23: 1050-6.
36. WATANABE Y, TOKUNAGA K, MATSUKI K, TAKKUCHI F, MATSUTA K, MAEDA H, OMOTO K, JUJI T: Putative amino acid sequence of HLA-DRB chain contributing to rheumatoid arthritis susceptibility. J Exp Med 1989; 169: 2263-8.
37. TAKEUCHI F, MATSUTA K, WATANABE Y, TOKUNAGA K, JUJI T, MIYAMOTO T: Susceptibility epitope on HLA-DR β chain for rheumatoid arthritis and the effect of the possibility on the clinical features. J Immunogenet 1989; 16: 475-83.
38. SAIKI RK, GELFAND DH, STOFFEL S, SCHARF SJ, HIGUCHI R, HOM GT, MULLIS KB, ERLICH HA: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487-91.
39. BECK S, KELLY A, RADLEY E, KHURSHID F, ALDERTON RP, TROWSDALE J: DNA sequence analysis of 66Kb of the human MHC class II region encoding a cluster of genes for antigen processing. J Mol Biol 1992; 228: 433-41.
40. OLERUP O, ZETTERQUIST H: HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225-35.
41. ORITA M, IWAHARA H, KANAZAWA H, HAYASHI K, SEKIYA T: Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989; 86: 2766-70.
42. YEWDELL JW, ESQUIVEL F, ARNOLD D, SPIES T, EISENLOHR LC, BENNINK JR: Presentation of numerous viral peptides to mouse major histocompatibility complex (MHC) class I-restricted T lymphocytes is mediated by the human MHC-encoded transporter or by a hybrid mouse-human transporter. J Exp Med 1993; 177: 1785-90.
43. GUE'GUEN M, BIDDISON WE, LONG EO: T cells recognition of an HLA-A2-restricted epitope derived from a cleaved signal sequence. J Exp Med 1994; 180: 1989-94.
44. BRAUD V, CHEVRIER D, CESBRON A, BIGNON JD, KAPLAN C, VALENTIN N, MULLER JY: Susceptibility to alloimmunization to platelet HPA-Ia antigen involves TAP1 polymorphism. Hum Immunol 1994; 41: 141-5.
45. KAMIKAWAJI N, KIMURA A, TSUCHIYA K, SASAZUKI T: Association of HLA with sensitivity and resistance for rheumatoid arthritis. 1992 Annual Report of the Ministry of Health and Welfare Rheumatoid Arthritis Research Committee 1993: 25-7 (in Japanese).
46. NAKANISHI K, KOBAYASHI T, MURASE T, NAKATSUJI T, INOKO H, TSUJI K, KOSAKA K: Association of HLA-A24 with complete β-cell destruction in insulin-dependent diabetes mellitus. Diabetes 1993; 42: 1086-93.
47. TIWARI JL, TERASAKI PI: HLA and Disease Association. New York, Springer-Verlag, 1985; 22-3.
48. SINGAL DP, YE M, QIU X, D'SOUZA M: Polymorphism in the TAP2 gene and their association with rheumatoid arthritis. Clin Exp Rheumatol 1994; 1 2: 29-33.
49. NAKANISHI K, KOBAYASHI T, MURASE T, KOSAKA K: Lack of association of the transporter associated with antigen processing with Japanese insulin-dependent diabetes mellitus. Metabolism 1994; 43: 1013-7.
50. BURNEY RO, PILE KO, GIBSON K, CALIN A, KENNEDY LG, SINNOTT PJ, POWIS SH, WORDSWORTH BP: Analysis of the MHC class II encoded components of the HLA class I antigen processing pathway in ankylosing spondylitis. Ann Rheum Dis 1994; 53: 58-60.
51. PLOSKI R, UNDLIEN DE, VINJE O, FORRE O, THORSBY E, RONNINGEN KS: Polymorphism of human major histocompatibility complex-encoded transporter associated with antigen processing (TAP) gene and susceptibility to juvenile rheumatoid arthritis: Hum Immunol 1994; 39: 54-60.
52. DONN RP, DAVIES EJ, HOLT PL, THOMSON W, OLLIER W: Increased frequency of TAP2B in early onset pauciarticular juvenile chronic arthritis. Ann Rheum Dis 1994; 53: 261-4,
53. WORDSWORTH BP, PILE KD, GIBSON K, BURNEY RO, MOCKRIDGE I, POWIS SH: Analysis of the MHC-encoded transporters TAP1 and TAP2 in rheumatoid arthritis: linkage with DR4 accounts for the association with minor TAP2 allele. Tissue Antigens 1993; 42: 153-5.